A recent study presented at the American Academy of Paediatrics 2026 National Conference in San Diego has revealed a sharp increase in colorectal cancer cases among children and teenagers in Kenya. The retrospective analysis of 84 medical records from young patients diagnosed between 2012 and 2023 shows a significant upward trend in the past two decades. The study highlights a growing concern of colorectal cancer in patients 21 years old and younger.
The study found that cases of colorectal cancer among children aged 10-14 rose fivefold, more than tripled among teenagers aged 15-19, and nearly doubled in the 20-24 age group. The median age of the cohort was 16.5 years, and about 80% had no close family history of the disease. This suggests that the increasing trend may not be solely attributed to genetic factors.
Most patients were diagnosed at advanced stages, with over half diagnosed at Stage 3 and 29% already having Stage 4 disease. The four most common symptoms were abdominal or back pain, altered bowel habits, unexplained weight loss, and rectal bleeding. These symptoms were often misinterpreted as less serious conditions due to the rarity of colorectal cancer in young people.
The study also found that treatment modalities included surgery, chemotherapy, and radiation, but about 37% of patients experienced disease recurrence. By the end of the study period, 38 of the 84 patients had died from colorectal cancer, highlighting the seriousness of late-stage disease in this age group. The high mortality rate underscores the need for early detection and treatment.
Researchers attribute the delayed diagnosis to the rarity of colorectal cancer in young people, which can lead clinicians to misinterpret symptoms. They recommend that persistent abdominal pain, bowel changes, weight loss, or rectal bleeding in young patients prompt thorough evaluation, including blood or stool tests, imaging, and colonoscopy where appropriate.
The authors stress the need for better coordination between pediatric and adult oncology teams to manage young patients with colorectal cancer. They also call for heightened clinical vigilance and further surveillance, especially in regions like Kenya where data on youth cases are scarce. The study's findings highlight a potential emerging public-health concern that warrants attention.
Despite the study's limited sample size of 84 patients from 34 institutions, which precludes definitive conclusions about national trends, it provides valuable insights into the increasing trend of colorectal cancer among Kenyan youth. The study's findings have significant implications for healthcare policy and practice in Kenya, emphasizing the need for increased awareness and improved diagnostic capabilities.
Key points
- Colorectal cancer cases among Kenyan children aged 10-14 have risen fivefold between 2012 and 2023.
- Most patients were diagnosed at advanced stages, with over half at Stage 3 and 29% at Stage 4.
- The study highlights the need for heightened clinical vigilance and better coordination between pediatric and adult oncology teams.
